Genetic Foresight’s mission is to prevent adverse drug reactions, increase therapeutic success rates, and minimize healthcare costs by enabling clinicians to make informed decisions. Founded in 2016, the company offers a genetic test that sequences targeted segments of patients' genomes and a comprehensive prescription decision platform that incorporates drug-genome, drug-drug, drug-disease, personal health, lifestyle, and medical and family histories to predict drug response.
Genetic Foresight has achieved significant milestones in personalized medicine, providing clinicians with tools to tailor treatments effectively. Their platform has improved patient outcomes by reducing adverse drug reactions and optimizing therapeutic strategies. The company's innovative approach has garnered attention from the healthcare community, positioning it as a leader in pharmacogenomics.
